Zacks Investment Research Lowers Grifols SA (GRFS) to Hold
Grifols SA (NASDAQ:GRFS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday.
According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain. “
Grifols SA (NASDAQ:GRFS) opened at 15.65 on Wednesday. The stock has a market capitalization of $21.39 billion, a P/E ratio of 35.49 and a beta of 0.92. The company has a 50-day moving average price of $16.16 and a 200 day moving average price of $16.04. Grifols SA has a 1-year low of $14.07 and a 1-year high of $18.04.
A number of hedge funds have recently made changes to their positions in the stock. Hansberger Growth Investors LP raised its stake in shares of Grifols SA by 2.6% in the second quarter. Hansberger Growth Investors LP now owns 90,273 shares of the company’s stock valued at $1,505,000 after buying an additional 2,253 shares in the last quarter. Fiera Capital Corp bought a new position in shares of Grifols SA during the second quarter worth approximately $890,000. FDx Advisors Inc. increased its position in shares of Grifols SA by 4.9% in the second quarter. FDx Advisors Inc. now owns 58,284 shares of the company’s stock worth $972,000 after buying an additional 2,743 shares during the last quarter. Capital Guardian Trust Co. increased its position in shares of Grifols SA by 2.2% in the second quarter. Capital Guardian Trust Co. now owns 421,336 shares of the company’s stock worth $7,024,000 after buying an additional 9,103 shares during the last quarter. Finally, Walleye Trading LLC increased its position in shares of Grifols SA by 31.0% in the second quarter. Walleye Trading LLC now owns 9,300 shares of the company’s stock worth $155,000 after buying an additional 2,200 shares during the last quarter. 20.18% of the stock is owned by hedge funds and other institutional investors.
Receive News & Stock Ratings for Grifols SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols SA and related stocks with our FREE daily email newsletter.